Ajay J. Kirtane, MD

Cardiovascular Disease, Interventional Cardiology
More specialties
Accepting New Patients
Virtual Visits/Telehealth
Profile Headshot



Ajay J. Kirtane, MD, SM, is Professor of Medicine at Columbia University Irving Medical Center and Director of the Cardiac Catheterization Laboratories at NewYork-Presbyterian/Columbia University Irving Medical Center. Dr. Kirtane is an internationally-renowned leader in Interventional Cardiology, specializing in the care of patients with complex coronary and peripheral vascular disease.

In addition to his clinical commitments, Dr. Kirtane has a strong interest in clinical education and research, serving as Chief Academic Officer of Columbia Interventional Cardiovascular Care. He is a co-director of the Cardiovascular Research Foundation’s Transcatheter Cardiovascular Therapeutics (TCT) conference, has served as a director of several international, national, and regional educational conferences, and has participated on the program committees for the scientific sessions of both the American College of Cardiology and American Heart Association. Dr. Kirtane’s research interests are in clinical trial methodology and outcomes of device-based and pharmacologic interventions in Interventional Cardiology. He has authored over 350 original manuscripts and over 80 reviews and editorials including the “Coronary Stenting” chapters of the two most widely used textbooks in Interventional Cardiology. He is/has been Principal Investigator and serves on the steering committees of several clinical trials in interventional cardiovascular medicine.

Born in Brooklyn, New York, and raised in Bergen County, New Jersey, Dr. Kirtane is a graduate of Princeton University and Columbia University College of Physicians and Surgeons, and completed his residency/chief residency in Internal Medicine at the University of California – San Francisco. He then completed fellowships in Cardiovascular Disease and Coronary and Peripheral Vascular Intervention at Beth Israel Deaconess Medical Center / Harvard Medical School and additionally obtained a Masters of Science in Clinical Epidemiology from the Harvard School of Public Health prior to moving back to Columbia. In his free time, Dr. Kirtane has avid interests in running, tennis, skiing, and music, and lives in New Jersey with his wife, 2 children, and their dog Oliver.

Areas of Expertise / Conditions Treated

  • Endovascular Intervention
  • Peripheral Arterial Intervention
  • Renal Denervation for Hypertension
  • Stents
  • Transradial Catheterization
  • Vascular Medicine

Academic Appointments

  • Professor of Medicine at CUMC

Administrative Titles

  • Director, NYP/Columbia Cardiac Catheterization Laboratories
  • Chief Academic Officer, Center for Interventional Vascular Therapy

Hospital Affiliations

  • NewYork-Presbyterian / Columbia University Irving Medical Center


  • Male

Schedule an Appointment

Virtual Visits/Telehealth

Virtual Visits allow you to connect with your provider from the comfort, convenience, and safety of your own home.

Schedule Virtual Visit

Phone Appointments

New and Existing Patients:

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.

Connect Sign In


161 Fort Washington Avenue
New York, NY 10032

Insurance Accepted


  • Aetna Signature Administrators
  • EPO
  • HMO
  • Medicare Managed Care
  • NYP Employee Plan
  • NY Signature
  • POS
  • PPO
  • Student Health

Affinity Health Plan

  • Essential Plan
  • Medicaid Managed Care


  • Medicare Managed Care
  • Special Needs

Amida Care

  • Special Needs


  • EPO
  • Great West (National)
  • HMO
  • POS
  • PPO

MagnaCare (National)

  • MagnaCare


  • Railroad
  • Traditional Medicare


  • Multiplan

MVP Health Care

  • Child/Family Health Plus
  • Essential Plan
  • HMO
  • Medicaid Managed Care

Oxford Health Plans

  • Freedom
  • Liberty

Quality Health Management

  • Quality Health Management


  • Special Needs


  • Columbia University Employee Plan
  • Compass (Exchange)
  • Empire Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO


  • Medicare Managed Care
  • SelectHealth
  • Special Needs


  • Medicaid Managed Care
  • Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

  • AB, 1994 Princeton University
  • MD, 1998 Columbia University College of Physicians and Surgeons
  • 1998 Columbia University College of Physicians and Surgeons
  • 2005 Harvard School of Public Health
  • SM, 2005 Harvard School of Public Health
  • Internship: 1999 University of California-San Francisco Medical Center
  • Residency: 2002 University of California-San Francisco Medical Center
  • Fellowship: 2006 Harvard Medical School/ Beth Israel Deaconess Medical Center

Board Certifications

  • Cardiovascular Disease
  • Interventional Cardiology

Honors & Awards

Columbia University Medical Center:
2009 Ewig Clinical Teaching Award (three-year funded award), Department of Medicine
2010 Daniel V. Kimberg Junior Faculty Teaching Award, Department of Medicine (given annually to a single recipient)
2012 Participant (by nomination/acceptance) in P&S Leadership & Management Institute

American College of Cardiology:
2010 Selected as American College of Cardiology’s Emerging Faculty

Harvard Medical School:
2005 George E. Altman, M.D. and Harriet Altman Annual Cardiology Fellow Award

University of California San Francisco:
2000 Selected as Chief Medical Resident for 2001-2002 academic year

Columbia University College of Physicians and Surgeons:
1998 Marie Nercessian Memorial Award for Humanism in Medicine
1998 Membership in Alpha Omega Alpha Society

1996 Gregory Grove Memorial Scholarship (given to the highest-ranking student in the second year class), co-recipient

Princeton University:
1994 E.R. Squibb and Sons Senior Thesis Prize for Contributions to Scientific Research
1994 Membership in Phi Beta Kappa Society
1994 Membership in Society of Sigma Xi

America's Top Doctor
NY Top Doctor


Dr. Kirtane’s research interests are in clinical trial methodology and outcomes of device-based and pharmacologic interventions in Interventional Cardiology. He is/has been Principal Investigator for several multicenter trials of interventional devices and serves on the steering committees of several large-scale clinical trials in interventional cardiovascular medicine.

Selected Publications

  1. Kirtane AJ, Parikh PB, Stuckey TD, Xu K, Witzenbichler B, Weisz G, Rinaldi MJ, Neumann FJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Brodie BR, Mazzaferri EL Jr, Parvataneni R, Maehara A, Généreux P, Mehran R, Stone GW. Is There an Ideal Level of Platelet P2Y12-Receptor Inhibition in Patients Undergoing Percutaneous Coronary Intervention?: "Window" Analysis From the ADAPT-DES Study (Assessment of Dual AntiPlatelet Therapy With Drug-Eluting Stents). JACC Cardiovasc Interv. 2015 Dec 28;8(15):1978-87.
  2. Kirtane AJ, King SB 3rd. Should all stent patients have prolonged dual antiplatelet therapy? JACC Cardiovasc Interv. 2015 May;8(6):873-5.
  3. Kirtane AJ, Kelly CR. Clearing the air on the "smoker's paradox". J Am Coll Cardiol. 2015 Mar 24;65(11):1116-8.
  4. Kirtane AJ, Stone GW. STEMI care in China: a world opportunity. Lancet. 2015 Jan 31;385(9966):400-1.
  5. Kirtane AJ, Leon MB, Ball MW, Bajwa HS, Sketch MH Jr, Coleman PS, Stoler RC, Papadakos S, Cutlip DE, Mauri L, Kandzari DE; ENDEAVOR IV Investigators. The "final" 5-year follow-up from the ENDEAVOR IV trial comparing a zotarolimus-eluting stent with a paclitaxel-eluting stent. JACC Cardiovasc Interv. 2013 Apr;6(4):325-33.
  6. Kirtane AJ, Leon MB. The Placement of Aortic Transcatheter Valve (PARTNER) trial: clinical trialist perspective. Circulation. 2012 Jun 26;125(25):3229-32.
  7. Kirtane AJ, Stone GW. How to minimize stent thrombosis. Circulation. 2011 Sep 13;124(11):1283-7.
  8. Kirtane AJ, Gupta A, Iyengar S, Moses JW, Leon MB, Applegate R, Brodie B, Hannan E, Harjai K, Jensen LO, Park SJ, Perry R, Racz M, Saia F, Tu JV, Waksman R, Lansky AJ, Mehran R, Stone GW. Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies. Circulation. 2009 Jun 30;119(25):3198-206.
  9. Kirtane AJ, Ellis SG, Dawkins KD, Colombo A, Grube E, Popma JJ, Fahy M, Leon MB, Moses JW, Mehran R, Stone GW. Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials. J Am Coll Cardiol. 2008 Feb 19;51(7):708-15.
  10. Jeremias A, Kirtane A. Balancing efficacy and safety of drug-eluting stents in patients undergoing percutaneous coronary intervention. Ann Intern Med. 2008 Feb 5;148(3):234-8.
  11. Kirtane AJ, Piazza G, Murphy SA, Budiu D, Morrow DA, Cohen DJ, Peterson E, Lakkis N, Herrmann HC, Palabrica TM, Gibson CM; TIMI Study Group. Correlates of bleeding events among moderate- to high-risk patients undergoing percutaneous coronary intervention and treated with eptifibatide: observations from the PROTECT-TIMI-30 trial. J Am Coll Cardiol. 2006 Jun 20;47(12):2374-9.
  12. Kirtane AJ, Martinezclark P, Rahman AM, Ray KK, Karmpaliotis D, Murphy SA, Giugliano RP, Cannon CP, Antman EM, Roe MT, Harrington RA, Ohman EM, Braunwald E, Gibson CM. Association of smoking with improved myocardial perfusion and the angiographic characterization of myocardial tissue perfusion after fibrinolytic therapy for ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2005 Jan 18;45(2):321-3.